Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-007754

Director bought 7,000 shares at $1.40 ($9,800)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mulroy Michael H. Director 2022-03-24 Purchase +7,000 $1.40 $9,800 258,555 D
Open-market purchases · 7,000 sh · avg $1.40 · $9,800
Loading xslF345X03/ownership.xml…